155 related articles for article (PubMed ID: 10089080)
1. Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma.
Tseleni-Balafouta S; Kavantzas N; Alevizaki M; Paraskevakou H; Davaris P
J Exp Clin Cancer Res; 1998 Dec; 17(4):533-7. PubMed ID: 10089080
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
[TBL] [Abstract][Full Text] [Related]
3. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
Koljonen V; Haglund C; Tukiainen E; Böhling T
Anticancer Res; 2005; 25(2A):853-8. PubMed ID: 15868919
[TBL] [Abstract][Full Text] [Related]
8. Findings of computerised nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors.
Tseleni S; Kavantzas N; Yova D; Alexandratou E; Karydakis V; Gogas J; Davaris P
J Exp Clin Cancer Res; 1997 Dec; 16(4):401-6. PubMed ID: 9505213
[TBL] [Abstract][Full Text] [Related]
9. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
10. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
11. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
Zeiger MA; Dackiw AP
J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
[TBL] [Abstract][Full Text] [Related]
12. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
Abrahamsson PA; Cockett AT; di Sant'Agnese PA
Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnostic methods for papillary carcinoma of the thyroid].
Solymosi T
Orv Hetil; 2000 May; 141(19):1048-50. PubMed ID: 10846427
[No Abstract] [Full Text] [Related]
16. [Immunohistochemical and morphometric studies on neuroendocrine differentiation of prostate carcinomas].
Bohrer MH; Schmoll J
Verh Dtsch Ges Pathol; 1993; 77():107-10. PubMed ID: 7511265
[TBL] [Abstract][Full Text] [Related]
17. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
19. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
Gemsenjäger E; Schweizer I
Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
